Legal & General Group
ATRS

Legal & General Group’s Antares Pharma, Inc. ATRS Stock Holding History

Legal & General Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-65,751
Closed -$270K – 3759
2022
Q1 		$270K Hold
65,751
– – ﹤0.01% 2569
2021
Q4 		$235K Buy
65,751
+410
+0.6% +$1.43K ﹤0.01% 2661
2021
Q3 		$238K Buy
65,341
+30,914
+90% +$125K ﹤0.01% 2631
2021
Q2 		$150K Buy
34,427
+4,934
+17% +$20.1K ﹤0.01% 2612
2021
Q1 		$121K Buy
29,493
+6,822
+30% +$29.6K ﹤0.01% 2568
2020
Q4 		$90K Sell
22,671
-1,153
-5% -$3.73K ﹤0.01% 2616
2020
Q3 		$65K Sell
23,824
-6,982
-23% -$19.3K ﹤0.01% 2604
2020
Q2 		$85K Buy
30,806
+1,598
+5% +$4.46K ﹤0.01% 2572
2020
Q1 		$68K Sell
29,208
-7,662
-21% -$26.1K ﹤0.01% 2516
2019
Q4 		$173K Buy
36,870
+6,316
+21% +$25.8K ﹤0.01% 2431
2019
Q3 		$102K Hold
30,554
– – ﹤0.01% 2515
2019
Q2 		$101K Buy
30,554
+3,681
+14% +$10.6K ﹤0.01% 2524
2019
Q1 		$82K Buy
26,873
+1,629
+6% +$5.28K ﹤0.01% 2553
2018
Q4 		$69K Buy
25,244
+3,587
+17% +$11.8K ﹤0.01% 2577
2018
Q3 		$73K Hold
21,657
– – ﹤0.01% 2600
2018
Q2 		$56K Sell
21,657
-4,237
-16% -$10.5K ﹤0.01% 2700
2018
Q1 		$57K Sell
25,894
-11,495
-31% -$25.9K ﹤0.01% 2692
2017
Q4 		$75K Hold
37,389
– – ﹤0.01% 2718
2017
Q3 		$121K Sell
37,389
-41
-0.1% -$127 ﹤0.01% 2546
2017
Q2 		$120K Buy
+37,430
New +$106K ﹤0.01% 2509
2016
Q2 		– Sell
-28,381
Closed -$25K – 2938
2016
Q1 		$25K Hold
28,381
– – ﹤0.01% 2636
2015
Q4 		$35K Hold
28,381
– – ﹤0.01% 2597
2015
Q3 		$48K Buy
28,381
+2,450
+9% +$4.8K ﹤0.01% 2474
2015
Q2 		$55K Buy
25,931
+7,238
+39% +$17.6K ﹤0.01% 2498
2015
Q1 		$50K Hold
18,693
– – ﹤0.01% 2488
2014
Q4 		$49K Hold
18,693
– – ﹤0.01% 2446
2014
Q3 		$35K Buy
+18,693
New +$40.8K ﹤0.01% 2542

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Legal & General Group's ATRS Position: Q2 2022 in Review

Legal & General Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 65,751 shares — an estimated $270K sold.

Legal & General Group first reported a position in ATRS in Q3 2014 and held it in 27 quarters. The position peaked at $270K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Legal & General Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 65,751 Antares Pharma, Inc. shares in Q2 2022, an estimated $270K.
  • Legal & General Group first reported a position in Antares Pharma, Inc. in Q3 2014 and held it in 27 quarters.
  • Legal & General Group's Antares Pharma, Inc. position peaked at $270K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.